Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell linesOSHIMA, Goro; WENNERBERG, Johan; YAMATODANI, Takashi et al.Journal of cancer research and clinical oncology. 2012, Vol 138, Num 3, pp 491-499, issn 0171-5216, 9 p.Article

Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenograftsYAMATODANI, Takashi; HOLMQVIST, B. O; KJELLEN, Elisabeth et al.Acta oto-laryngologica. 2012, Vol 132, Num 12, pp 1324-1333, issn 0001-6489, 10 p.Article

Tumor Suppressor Activity and Inactivation of Galanin Receptor Type 2 by Aberrant Promoter Methylation in Head and Neck CancerMISAWA, Yuki; MISAWA, Kiyoshi; KANAZAWA, Takeharu et al.Cancer. 2014, Vol 120, Num 2, pp 205-213, issn 0008-543X, 9 p.Article

Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell linesYAMATODANI, Takashi; EKBLAD, Lars; KJELLEN, Elisabeth et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 3, pp 395-402, issn 0171-5216, 8 p.Article